The cannula can have a connector configured to be electrically connected to a source of electrical power; a tip comprising: a printed circuit board (PCB); a first LED operatively connected and attached to the PCB and configured to emit light in a first wavelength range; and a shell configured to allow the light in the first wavelength range to pass from the first LED outside of the shell; and a middle section located between the connector and the tip, the middle section comprising: a hollow tube attached to the shell, the tube having apertures for collecting a liquid fat into the tube.

An apparatus comprises a body assembly, a shaft, an acoustic waveguide, an articulation section, an end effector, and an articulation drive assembly. The shaft extends distally from the body assembly and defines a longitudinal axis. The acoustic waveguide comprises a flexible portion. The articulation section is coupled with the shaft. A portion of the articulation section encompasses the flexible portion of the waveguide. The articulation section comprises a plurality of body portions aligned along the longitudinal axis and a flexible locking member. The flexible locking member is operable to secure the body portions in relation to each other and in relation to the shaft. The end effector comprises an ultrasonic blade in acoustic communication with the waveguide. The articulation drive assembly is operable to drive articulation of the articulation section to thereby deflect the end effector from the longitudinal axis.

Various systems and methods for determining the composition of tissue via an ultrasonic surgical instrument are disclosed. A control circuit can be configured to monitor the change in resonant frequency of an ultrasonic electromechanical system of the ultrasonic surgical instrument as the ultrasonic blade oscillates against a tissue and determine the composition of the tissue accordingly. In some aspects, the control circuit can be configured to modify the operation of the ultrasonic electromechanical system or other operational parameters of the ultrasonic surgical instrument according to the detected tissue composition.

Methods and systems for monitoring and modifying pulsed field ablation (PFA) energy delivery to prevent patient safety risks and/or delivery device failure. In particular, some embodiments provide methods and systems for detecting and preventing arcs and arc-induced plasma, and their causal events, during delivery of pulsed field ablation energy, as well as methods and systems for identifying conditions leading to potential delivery device failure and correcting charge imbalance or asymmetry.

An electrosurgical generator configured to generate electrical energy to be applied to biological tissue via electrical communication with an electrosurgical instrument, the electrosurgical generator including a power source configured to activate to output the electrical energy to the electrosurgical instrument, a measurement circuit configured to measure a resistive value associated with an erodible coating deposited on a portion of the electrosurgical instrument, and a control circuit configured to compare a measured resistive value of the erodible coating to a threshold resistive value of the coating, and control activation of the power source based on the comparison between the measured resistive value and the threshold resistive value.

Disclosed herein are systems, devices, and methods for treating heart failure. In some variations, a catheter for forming an anastomosis in a heart may comprise a first catheter comprising an electrode. A second catheter may be slidably disposed within the first catheter. The second catheter may comprise a barb and a dilator comprising a mating surface configured to engage the electrode.

Described herein is a method and system for gap detection in ablation lines. Microelectrodes are implemented at a distal tip of a catheter to provide localized gap detection along an ablation line. A pacing protocol is used to sequence through each of the microelectrode pairs for a tissue location. If living tissue is present, the pacing signal travels through the living tissue to pulse the heart. An operator will see a capture signal and know that there is a gap in the ablation line. The ablation electrode is then used to ablate the tissue in the gap. Pacing and ablation are therefore performed at the same place without the need to switch between instruments and/or catheters. In an implementation, a force sensor can automate the pacing protocol by determining which microelectrode pair is contacting the tissue. Moreover, signaling between microelectrode pairs can determine contact between the catheter and the tissue.

Devices and methods for tissue treatment produce a mechanical stimulation therapy and electromagnetic field therapy. The mechanical stimulation therapy provides stimulation of blood circulation and stimulates treated cells. The electromagnetic field enables thermal treatment of tissue. Combination of both therapies improves soft tissue treatment, mainly connective tissue in the skin area and fat reduction.

A method for treating patients who suffer from chronic rhinitis that is efficient and causes fewer adverse effects than known methods. This is achieved by using a handheld surgical instrument, more particularly an electrosurgical applicator, for treatment of hypertrophic nasal conchae and/or for submucosal treatment of the posterior nasal nerve (PNN) in order to reduce at least one cardinal symptom of chronic rhinitis.

Planar end effector designs having irrigation are presented. The example end effectors are configured to be affixed to a distal end of a catheter and delivered through vasculature in a collapsed configuration and expand at an intracardiac treatment site to a deployed configuration. In some instances, the end effector can have an electrode array with sufficient density to perform mapping and irrigation for mapping. The end effector can include dedicated irrigation tubes and/or irrigating electrode-carrying spines to irrigate within the electrode array. Flow rate at positions within the electrode array can be controlled in a predetermined manner by varying pore/port size, flow direction, and/or flow path cross-section throughout an irrigation flow path in the end effector.